A PUBLIC health advocacy group has helped blow the lid off a brazen heist— the attempt by a US drug company to corner the intellectual property rights (IPRS) on a covid-19 vaccine it developed in collaboration with the government. The company is Moderna, the darling of both Wall Street because of its ability to garner huge funds, and of public health campaigners because of its promise of sharing its technology. But corporate greed has seen the unraveling of a model partnership that would bring new drugs quickly to the market and ensure fair pricing.
It is an egregious appropriation because the vaccine is the result of a four-year collaboration between Moderna and the US National Institutes of Health (NIH); the government described it as the NIH-Moderna covid-19 vaccine in its documents. Although the company had not brought a single product into the market previously, the government had poured billions into the research project, which accelerated after the pandemic struck. Most estimates have put the funding it received from various government agencies at the US $2.5 billion, but a recent New York Times (NYT) report says Moderna has received nearly $10 billion in taxpayer funding “to develop the vaccine, test it and provide doses to the federal government”.
The dream of a people’s vaccine, as it was dubbed last year by public health campaigners, is fading fast as the controversy over who should be credited with developing the vaccine heads for the courts. That is because the government is finally saying enough is enough and is contesting Moderna’s claims of having developed the vaccine on its own. NIH is, in a surprising and heartening turn, insisting that its scientists who developed the technology be credited in the patent application made by the company.
This story is from the December 01, 2021 edition of Down To Earth.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the December 01, 2021 edition of Down To Earth.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
In leading role again
MOVIES AND WEB SERIES ARE ONCE AGAIN BEING SET IN RUSTIC BACKGROUNDS, INDICATING A RECONNECT BETWEEN CINEMA AND THE COUNTRYSIDE
One Nation One Subscription comes at a huge cost
As top US universities scrap big deals with top scientific publishers, India’s ONOS scheme seems flawed and outdated
Return of Rambhog
Bid to revive and sell the aromatic indigenous paddy variety has led to substantial profits for farmers in Uttar Pradesh's Terai region
Scarred by mining
Natural springs of Kashmir drying up due to illegal riverbed mining
Human-to-human spread a mutation away
CANADA IN mid-November confirmed its first human case of avian influenza, with a teenager in the British Columbia being hospitalised after contracting the H5N1 virus that causes the disease. The patient developed a severe form of the disease, also called bird flu, and had respiratory issues. There was no known cause of transmission.
True rehabilitation
Residents of Madhya Pradesh's Kakdi village take relocation as an opportunity to undertake afforestation, develop sustainable practices
INESCAPABLE THREAT
Chemical pollution is the most underrated and underreported risk of the 21st century that threatens all species and regions
THAT NIGHT, 40 YEARS AGO
Bhopal gas disaster is a tragedy that people continue to face
A JOKE, INDEED
A CONFERENCE OF IRRESPONSIBLE PARTIES THAT CREATED AN OPTICAL ILLUSION TO THE REALITY OF A NEW CLIMATE
THINGS FALL APART
THE WORLD HAS MADE PROGRESS IN MITIGATING EMISSIONS AND ADAPTING TO CLIMATE IMPACTS. BUT THE PROGRESS REMAINS GROSSLY INADEQUATE